IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q2 EPS of ($0.88), $0.09 worse than the analyst estimate of ($0.79).

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Edge Total Intelligence Provides Business Update: Preliminary Second Quarter and First-Half Revenue, Special AGM Matters, and Strategic Growth
• Selloff in this renewable energy stock is overdone, BofA says